386 related articles for article (PubMed ID: 9485533)
1. The role of melatonin and circadian phase in age-related sleep-maintenance insomnia: assessment in a clinical trial of melatonin replacement.
Hughes RJ; Sack RL; Lewy AJ
Sleep; 1998; 21(1):52-68. PubMed ID: 9485533
[TBL] [Abstract][Full Text] [Related]
2. Efficacy of prolonged release melatonin in insomnia patients aged 55-80 years: quality of sleep and next-day alertness outcomes.
Wade AG; Ford I; Crawford G; McMahon AD; Nir T; Laudon M; Zisapel N
Curr Med Res Opin; 2007 Oct; 23(10):2597-605. PubMed ID: 17875243
[TBL] [Abstract][Full Text] [Related]
3. Entrainment of free-running circadian rhythms by melatonin in blind people.
Sack RL; Brandes RW; Kendall AR; Lewy AJ
N Engl J Med; 2000 Oct; 343(15):1070-7. PubMed ID: 11027741
[TBL] [Abstract][Full Text] [Related]
4. Effect of melatonin-rich night-time milk on sleep and activity in elderly institutionalized subjects.
Valtonen M; Niskanen L; Kangas AP; Koskinen T
Nord J Psychiatry; 2005; 59(3):217-21. PubMed ID: 16195124
[TBL] [Abstract][Full Text] [Related]
5. Prediction of melatonin efficacy by pretreatment dim light melatonin onset in children with idiopathic chronic sleep onset insomnia.
van der Heijden KB; Smits MG; van Someren EJ; Boudewijn Gunning W
J Sleep Res; 2005 Jun; 14(2):187-94. PubMed ID: 15910516
[TBL] [Abstract][Full Text] [Related]
6. Effect of melatonin on sleep, behavior, and cognition in ADHD and chronic sleep-onset insomnia.
Van der Heijden KB; Smits MG; Van Someren EJ; Ridderinkhof KR; Gunning WB
J Am Acad Child Adolesc Psychiatry; 2007 Feb; 46(2):233-41. PubMed ID: 17242627
[TBL] [Abstract][Full Text] [Related]
7. Melatonin agonist tasimelteon (VEC-162) for transient insomnia after sleep-time shift: two randomised controlled multicentre trials.
Rajaratnam SM; Polymeropoulos MH; Fisher DM; Roth T; Scott C; Birznieks G; Klerman EB
Lancet; 2009 Feb; 373(9662):482-91. PubMed ID: 19054552
[TBL] [Abstract][Full Text] [Related]
8. Nocturnal melatonin secretion and sleep after doxepin administration in chronic primary insomnia.
Hajak G; Rodenbeck A; Adler L; Huether G; Bandelow B; Herrendorf G; Staedt J; Rüther E
Pharmacopsychiatry; 1996 Sep; 29(5):187-92. PubMed ID: 8895944
[TBL] [Abstract][Full Text] [Related]
9. Melatonin decreases daytime challenging behaviour in persons with intellectual disability and chronic insomnia.
Braam W; Didden R; Maas AP; Korzilius H; Smits MG; Curfs LM
J Intellect Disabil Res; 2010 Jan; 54(1):52-9. PubMed ID: 19888921
[TBL] [Abstract][Full Text] [Related]
10. An efficacy, safety, and dose-response study of Ramelteon in patients with chronic primary insomnia.
Erman M; Seiden D; Zammit G; Sainati S; Zhang J
Sleep Med; 2006 Jan; 7(1):17-24. PubMed ID: 16309958
[TBL] [Abstract][Full Text] [Related]
11. Endogenous melatonin predicts efficacy of exogenous melatonin in consolidation of fragmented wrist-activity rhythm of adult patients with developmental brain disorders: a double-blind, placebo-controlled, crossover study.
Laakso ML; Lindblom N; Leinonen L; Kaski M
Sleep Med; 2007 Apr; 8(3):222-39. PubMed ID: 17368097
[TBL] [Abstract][Full Text] [Related]
12. Melatonin improves health status and sleep in children with idiopathic chronic sleep-onset insomnia: a randomized placebo-controlled trial.
Smits MG; van Stel HF; van der Heijden K; Meijer AM; Coenen AM; Kerkhof GA
J Am Acad Child Adolesc Psychiatry; 2003 Nov; 42(11):1286-93. PubMed ID: 14566165
[TBL] [Abstract][Full Text] [Related]
13. [Melatonin--a natural hypnotic?].
Saletu B
Wien Klin Wochenschr; 1997 Oct; 109(18):714-21. PubMed ID: 9441514
[TBL] [Abstract][Full Text] [Related]
14. Melatonin treatment for age-related insomnia.
Zhdanova IV; Wurtman RJ; Regan MM; Taylor JA; Shi JP; Leclair OU
J Clin Endocrinol Metab; 2001 Oct; 86(10):4727-30. PubMed ID: 11600532
[TBL] [Abstract][Full Text] [Related]
15. A randomized, placebo-controlled trial of controlled release melatonin treatment of delayed sleep phase syndrome and impaired sleep maintenance in children with neurodevelopmental disabilities.
Wasdell MB; Jan JE; Bomben MM; Freeman RD; Rietveld WJ; Tai J; Hamilton D; Weiss MD
J Pineal Res; 2008 Jan; 44(1):57-64. PubMed ID: 18078449
[TBL] [Abstract][Full Text] [Related]
16. Melatonin for chronic insomnia in Angelman syndrome: a randomized placebo-controlled trial.
Braam W; Didden R; Smits MG; Curfs LM
J Child Neurol; 2008 Jun; 23(6):649-54. PubMed ID: 18539989
[TBL] [Abstract][Full Text] [Related]
17. Treating chronobiological components of chronic insomnia.
Lack LC; Wright HR
Sleep Med; 2007 Sep; 8(6):637-44. PubMed ID: 17383935
[TBL] [Abstract][Full Text] [Related]
18. The partial positive allosteric GABA(A) receptor modulator EVT 201 is efficacious and safe in the treatment of adult primary insomnia patients.
Walsh JK; Thacker S; Knowles LJ; Tasker T; Hunneyball IM
Sleep Med; 2009 Sep; 10(8):859-64. PubMed ID: 19345644
[TBL] [Abstract][Full Text] [Related]
19. The effect of prolonged-release melatonin on sleep measures and psychomotor performance in elderly patients with insomnia.
Luthringer R; Muzet M; Zisapel N; Staner L
Int Clin Psychopharmacol; 2009 Sep; 24(5):239-49. PubMed ID: 19584739
[TBL] [Abstract][Full Text] [Related]
20. Melatonin in wake-sleep disorders in children, adolescents and young adults with mental retardation with or without epilepsy: a double-blind, cross-over, placebo-controlled trial.
Coppola G; Iervolino G; Mastrosimone M; La Torre G; Ruiu F; Pascotto A
Brain Dev; 2004 Sep; 26(6):373-6. PubMed ID: 15275698
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
